Bard Associates’s DarioHealth DRIO Stock Holding History

Bard Associates’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-190	Closed	-$23K	–	165
2019 Q3	$23K	Sell	190 -4	-2%	-$692	0.01%	161
2019 Q2	$36K	Sell	194 -2	-1%	-$519	0.02%	159
2019 Q1	$58K	Sell	196 -2	-1%	-$594	0.03%	158
2018 Q4	$61K	Sell	198 -9	-4%	-$3.23K	0.04%	163
2018 Q3	$80K	Sell	207 -5	-2%	-$2.29K	0.04%	163
2018 Q2	$109K	Sell	212 -10	-5%	-$6.53K	0.05%	160
2018 Q1	$137K	Sell	222 -31	-12%	-$18.9K	0.07%	151
2017 Q4	$164K	Sell	253 -39	-13%	-$26.4K	0.08%	148
2017 Q3	$215K	Hold	292	–	–	0.1%	151
2017 Q2	$255K	Hold	292	–	–	0.12%	147
2017 Q1	$352K	Sell	292 -12	-4%	-$17.8K	0.16%	124
2016 Q4	$395K	Sell	304 -3	-1%	-$3.92K	0.18%	119
2016 Q3	$436K	Sell	307 -2	-0.6%	-$3.14K	0.21%	113
2016 Q2	$637K	Buy	+309	New	+$631K	0.34%	97

Other funds holding DRIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return

HIA

Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Bard Associates's DRIO Position: Q4 2019 in Review

Bard Associates sold out of DarioHealth (DRIO) in Q4 2019, closing a stake of 190 shares — an estimated $23K sold.

Bard Associates first reported a position in DRIO in Q2 2016 and held it in 14 quarters. The position peaked at $637K in Q2 2016. 12 funds tracked by Wall St. Rank hold DRIO as of Q4 2019.

Bard Associates reported no remaining DarioHealth position as of Q4 2019 after selling out during the quarter.
Bard Associates sold 190 DarioHealth shares in Q4 2019, an estimated $23K.
Bard Associates first reported a position in DarioHealth in Q2 2016 and held it in 14 quarters.
Bard Associates's DarioHealth position peaked at $637K in Q2 2016.
12 funds tracked by Wall St. Rank held DarioHealth as of Q4 2019.

Based on Bard Associates's 13F filing for Q4 2019, filed 13 Feb 2020.